Page last updated: 2024-12-05

4-bromobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Bromobenzoic acid is a white solid organic compound used in various applications. It can be synthesized by bromination of benzoic acid. Its importance lies in its role as a precursor for other organic compounds, particularly in the pharmaceutical industry. It is often studied due to its potential biological activities and applications. For example, it is used in the synthesis of pharmaceuticals such as anti-inflammatory drugs, antibacterial agents, and anti-tumor drugs.'

4-bromobenzoic acid : A bromobenzoic acid carrying a single bromo subsituent at the 4-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11464
CHEMBL ID22051
CHEBI ID60698
SCHEMBL ID71380

Synonyms (64)

Synonym
p-carboxybromobenzene
einecs 209-581-7
brn 1906923
p-bromobenzenecarboxylic acid
ai3-08859
nsc 17582
benzoic acid, p-bromo-
4-bromobenzoic acid
586-76-5
benzoic acid, 4-bromo-
nsc17582
p-bromobenzoic acid
nsc-17582
inchi=1/c7h5bro2/c8-6-3-1-5(2-4-6)7(9)10/h1-4h,(h,9,10
STK301567
nsc-176126
nsc-143357
4-bromobenzoic acid, 98%
B-5782
B0553
4-bromo-benzoic acid
CHEMBL22051
AKOS000118916
Z82 ,
4-carboxybromobenzene
4-brom-benzoesaeure
CHEBI:60698 ,
4-09-00-01017 (beilstein handbook reference)
6992p6102o ,
unii-6992p6102o
FT-0649860
PS-5301
AM20050209
4-bromobenzoic acid [mi]
bromobenzoic acid, p-
4-bromobenzenecarboxylic acid
AE-641/00396064
SCHEMBL71380
AB00376738-03
para bromo benzoic acid
4-bromophenylcarboxylic acid
4-bromo benzoic acid
4- bromobenzoic acid
4-brom-benzoic acid
4bromo-benzoic acid
DTXSID7060413
F2191-0080
W-105369
STR02440
BP-31040
mfcd00002529
Z57127530
4-bromobenzoic acid, vetec(tm) reagent grade, 98%
CS-W020100
4-bromobenzoic acid (1)
bdbm239163
SY001067
NCGC00340397-01
Q18472729
4-brombenzoic acid
4-bromobenzoicacid
EN300-18038
mfcd06658868
SY345159
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
bromobenzoic acidAny benzoic acid carrying at least one bromo substituent on the benzene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-carbonic anhydrase 1Mycobacterium tuberculosis H37RvKi2.51330.00483.38419.8400AID1803218
Carbonic anhydrase 2Mycobacterium tuberculosis H37RvKi2.51330.00902.20969.8400AID1803218
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1145605Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145616Increase in membrane potential in mollusc neurons assessed as conductance of potassium at pH 7.8 relative to salicylic acid1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1145614Dissociation constant, pKa of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID125426Compound was tested for toxicity, calculated from isotoxic concentrations of substituted benzoic acids for 50% mortality of mosquito1983Journal of medicinal chemistry, Sep, Volume: 26, Issue:9
Ion-sensitive electrode potentiometry of organic anions: application to quantitative structure-activity relationships.
AID226478Hammett constant was evaluated1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
AID226477Hammett constant was determined1993Journal of medicinal chemistry, Oct-01, Volume: 36, Issue:20
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
AID1145615Dissociation constant, pKa of the compound at pH 7.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID28691log LD50 was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID28497log (1/C') was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1145607Octanol-aqueous phase distribution coefficient, log D of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1803218CA Inhibition Assay from Article 10.3109/14756366.2011.650168: \\Inhibition of the u00DF-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.\\2013Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 28, Issue:2
Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.77 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index68.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]